BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25895128)

  • 21. Deregulation of the CXCL12/CXCR4 axis in methotrexate chemotherapy-induced damage and recovery of the bone marrow microenvironment.
    Georgiou KR; Scherer MA; King TJ; Foster BK; Xian CJ
    Int J Exp Pathol; 2012 Apr; 93(2):104-14. PubMed ID: 22220905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
    Brachtl G; Sahakyan K; Denk U; Girbl T; Alinger B; Hofbauer SW; Neureiter D; Hofbauer JP; Egle A; Greil R; Hartmann TN
    PLoS One; 2011; 6(8):e23758. PubMed ID: 21876768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
    Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
    Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of undenatured whey protein supplementation on CXCL12- and CCL21-mediated B and T cell chemotaxis in diabetic mice.
    Badr G; Mohany M; Metwalli A
    Lipids Health Dis; 2011 Nov; 10():203. PubMed ID: 22070978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
    Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
    Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation.
    Calpe E; Purroy N; Carpio C; Abrisqueta P; Carabia J; Palacio C; Castellví J; Crespo M; Bosch F
    PLoS One; 2013; 8(12):e81221. PubMed ID: 24312539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase.
    Montresor A; Toffali L; Rigo A; Ferrarini I; Vinante F; Laudanna C
    Oncotarget; 2018 Oct; 9(80):35123-35140. PubMed ID: 30416684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1).
    Möhle R; Failenschmid C; Bautz F; Kanz L
    Leukemia; 1999 Dec; 13(12):1954-9. PubMed ID: 10602415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cells.
    Franitza S; Grabovsky V; Wald O; Weiss I; Beider K; Dagan M; Darash-Yahana M; Nagler A; Brocke S; Galun E; Alon R; Peled A
    Eur J Immunol; 2004 May; 34(5):1333-41. PubMed ID: 15114666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration.
    Redondo-Muñoz J; José Terol M; García-Marco JA; García-Pardo A
    Blood; 2008 Jan; 111(1):383-6. PubMed ID: 17890452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell Trafficking in Chronic Lymphocytic Leukemia.
    Davids MS; Burger JA
    Open J Hematol; 2012; 3(S1):. PubMed ID: 22844583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia.
    Patrussi L; Capitani N; Martini V; Pizzi M; Trimarco V; Frezzato F; Marino F; Semenzato G; Trentin L; Baldari CT
    Cancer Res; 2015 Oct; 75(19):4153-63. PubMed ID: 26282174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
    Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
    Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.
    Dal Bo M; Tissino E; Benedetti D; Caldana C; Bomben R; Del Poeta G; Gaidano G; Rossi FM; Zucchetto A; Gattei V
    Semin Hematol; 2014 Jul; 51(3):168-76. PubMed ID: 25048781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition.
    Pepper C; Buggins AG; Jones CH; Walsby EJ; Forconi F; Pratt G; Devereux S; Stevenson FK; Fegan C
    Leukemia; 2015 Mar; 29(3):744-7. PubMed ID: 25349153
    [No Abstract]   [Full Text] [Related]  

  • 36. Methods for Investigating VLA-4 (CD49d/CD29) Expression and Activation in Chronic Lymphocytic Leukemia and Its Clinical Applications.
    Zucchetto A; Tissino E; Chigaev A; Hartmann TN; Gattei V
    Methods Mol Biol; 2019; 1881():101-112. PubMed ID: 30350200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans.
    Troeger A; Johnson AJ; Wood J; Blum WG; Andritsos LA; Byrd JC; Williams DA
    Blood; 2012 May; 119(20):4708-18. PubMed ID: 22474251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes.
    Patrussi L; Capitani N; Cattaneo F; Manganaro N; Gamberucci A; Frezzato F; Martini V; Visentin A; Pelicci PG; D'Elios MM; Trentin L; Semenzato G; Baldari CT
    Oncogene; 2018 Mar; 37(11):1534-1550. PubMed ID: 29326436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12.
    McCaig AM; Cosimo E; Leach MT; Michie AM
    PLoS One; 2012; 7(11):e48929. PubMed ID: 23133664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
    Zucchetto A; Caldana C; Benedetti D; Tissino E; Rossi FM; Hutterer E; Pozzo F; Bomben R; Dal Bo M; D'Arena G; Zaja F; Pozzato G; Di Raimondo F; Hartmann TN; Rossi D; Gaidano G; Del Poeta G; Gattei V
    Blood; 2013 Nov; 122(19):3317-21. PubMed ID: 24068493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.